INDICATIONS     CONTRA-INDICATIONS     DOSAGE     SIDE-EFFECTS     PREGNANCY     OVERDOSE     IDENTIFICATION     PATIENT INFORMATION
FOLIGLOBIN TABLETS

SCHEDULING STATUS:
Not scheduled

PROPRIETARY NAME
(and dosage form):

FOLIGLOBIN TABLETS

COMPOSITION:
Each tablet contains:

	Ferrous sulphate	150,0 mg
	Folic acid	0,5 mg
	Ascorbic acid	50,0 mg
	Cyanocobalamin	5,0 mcg

PHARMACOLOGICAL CLASSIFICATION:
8.3 (Erythropoietics)

PHARMACOLOGICAL ACTION:
The ferrous sulphate is coated to ensure optimal release in the duodenum and prevent unpleasant gastric symptoms. Cyanocobalamin and folic acid are involved in the synthesis of nucleoproteins and thus assist in haemopoiesis. Ascorbic acid enhances the absorption of iron and assists erythrocyte maturation and production of haemoglobin.

INDICATIONS:
Iron deficiency anaemia, especially in female patients and pre-eminently during pregnancy.

CONTRA-INDICATIONS:
None

WARNINGS:
None

DOSAGE AND DIRECTIONS FOR USE:
1 tablet to be taken twice daily, after food.

SIDE-EFFECTS AND SPECIAL PRECAUTIONS:
Constipation and darkening of the stools may result from treatment with iron. This may be counteracted with a mild laxative.

KNOWN SYMPTOMS OF OVERDOSAGE AND PARTICULARS OF ITS TREATMENT:
Accidental ingestion by children may be dangerous and must be referred to a doctor at once.

IDENTIFICATION:
Dark red sugar-coated tablets.

PRESENTATION:
Containers of 30 and 60 tablets.

STORAGE INSTRUCTIONS:
Store in a cool, dry place below 25°C.
KEEP OUT OF REACH OF CHILDREN.

REGISTRATION NUMBER:
H.747 (Act 101/1965)

NAME AND BUSINESS ADDRESS OF APPLICANT:
Pahrmaceutical Enterprises (Pty) Ltd
Howard Studios, Howard Drive, Pinelands 7405

DATE OF PUBLICATION OF THIS PACKAGE INSERT:
October 1993

Updated on this site: March 2004
Source: Pharmaceutical Industry
SAEPI HOME PAGE      TRADE NAME INDEX      GENERIC NAME INDEX      FEEDBACK
Information presented by Malahyde Information Systems © Copyright 1996-2004